The U.S. Supreme Court has issued a significant ruling affecting hospitals that serve low-income Medicare beneficiaries, narrowing the interpretation of the Disproportionate Share Hospital (“DSH”) payment formula.  In Advocate Christ Medical Center v. Kennedy, the Court determined that only Medicare patients who were eligible to receive a cash Supplemental Security Income (“SSI”) payment during the month of their hospitalization may be included in the calculation for additional DSH reimbursement.  This decision represents a setback for more than 200 hospitals that had advocated for a broader, more inclusive definition of SSI entitlement, potentially reducing the financial support available for treating Medicare’s poorest patients. 

The DSH Program and the Medicare Fraction at Issue

Medicare, the government-funded health insurance program for elderly and disabled Americans, reimburses hospitals for inpatient services at standardized rates based on diagnosis-related groups.  Since this fixed-rate system does not account for the higher treatment costs of low-income patients—who often face greater health challenges and social service needs—Congress established the DSH adjustment to support hospitals serving these populations.  The DSH adjustment increases reimbursement to incentivize providers to maintain access for underserved patients.  

The DSH adjustment is calculated using two fractions:

  • Medicare fraction – the percentage of a hospital’s Medicare patients who are also entitled to SSI, a proxy for low-income Medicare beneficiaries. 
  • Medicaid fraction – the proportion of total patient days attributable to individuals not entitled to Medicare, but eligible for Medicaid.

This system ensures hospitals receive additional financial support for treating economically disadvantaged patients.

The dispute revolved around the calculation of the Medicare fraction—specifically, the definition of “entitled to [SSI] benefits” under 42 U.S.C. §1395ww(d)(5)(F)(vi)(I). 

More than 200 hospitals argued that all patients enrolled in SSI at the time of hospitalization should be counted, even if they did not receive an SSI payment during the month of their hospitalization.  They maintained that SSI entitlement continues unless an individual remains ineligible for 12 consecutive months and emphasized that SSI benefits extend beyond cash payments to include services like continued Medicaid coverage.  In contrast, the United States Department of Health and Human Services (“HHS”)—the federal agency tasked with calculating and administering the DSH adjustment—asserted that only patients who received an SSI cash payment during their hospitalization month qualified under the statute.  HHS emphasized that SSI is a monthly, cash-based benefit, meaning entitlement applies only when an individual is eligible for and receives payment in a given month. 

In a 7–2 decision, the Supreme Court sided with HHS.  The majority reasoned that SSI benefits consist of monthly cash payments provided to low-income individuals who meet certain financial and categorical eligibility criteria and did not include non-cash benefits such as ongoing Medicaid eligibility or access to vocational services.  The Court reasoned that the SSI program is structured to assess eligibility for those cash payments on a month-by-month basis, based on an individual’s income and resources during each specific month.  Accordingly, the Court determined a person may be eligible for a payment in one month and ineligible in the next, even if they remain otherwise enrolled in the SSI program. 

Building out from this understanding, the Court concluded that a Medicare patient is “entitled to SSI benefits” within the meaning of the Medicare fraction only if they receive an SSI cash payment during the month of their hospitalization.  In reaching this conclusion, the majority rejected the argument that general enrollment in the SSI program suffices to establish entitlement.  Rather, the Court reasoned that the phrase “entitled to benefits” in this context tracks the monthly cash-payment eligibility that defines the structure of the SSI program, thereby requiring that the Medicare beneficiary actually receive their SSI cash payment during the month of their hospitalization.  Because Congress specifically tied the Medicare fraction numerator to this entitlement, the Court held that hospitals may count only those Medicare patients whose monthly income and resource levels made them eligible for an SSI cash benefit during the month of hospitalization. 

The Court rejected the hospitals’ broader reading and dismissed the dissent’s arguments, which characterized the SSI benefit as a long-term, insurance-style entitlement.  The majority also rebuffed the notion that non-cash services (such as Medicaid continuation) could be counted as SSI benefits under the Medicare statute.  Finally, the Court held that the 12-month reapplication provision cited by the hospitals did not mean patients remained “entitled” to benefits during months of ineligibility—it merely required reenrollment after a year without payments. 

What’s Next?  Reimbursement Impacts for Safety-Net Hospitals

The Court’s decision reinforces a narrow, text-based approach to statutory interpretation in the Medicare context, and limits hospitals’ ability to count patients enrolled in—but not actively receiving—SSI as low-income for DSH reimbursement purposes.  While the ruling clarifies how the Medicare fraction must be calculated, it also lowers reimbursement for safety-net hospitals serving economically vulnerable populations.  Meanwhile, recent litigation in other courts has already begun to reshape related aspects of the DSH formula, signaling that judicial scrutiny of HHS’s interpretation of reimbursement provisions is far from settled.  Providers should thus assess how this decision may affect their DSH payments and monitor whether Congress or CMS pursue additional legislative or regulatory changes in response. 

Proskauer’s Health Care Group is closely monitoring developments in this area.  For more insights into this and related regulatory trends, subscribe to the Health Care Law Brief

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Vinay Kohli Vinay Kohli

Vinay Kohli is a healthcare industry lawyer.  Recognized for his focus and commitment to the healthcare industry, a wide range of healthcare businesses use Vinay as an outside general counsel to guide them on strategic planning, compliance matters, operational questions, and reimbursement concerns. …

Vinay Kohli is a healthcare industry lawyer.  Recognized for his focus and commitment to the healthcare industry, a wide range of healthcare businesses use Vinay as an outside general counsel to guide them on strategic planning, compliance matters, operational questions, and reimbursement concerns.  He provides regulatory, compliance, and reimbursement advice on topics that range from venture formation, technology implementation, and risk management to day-to-day contract negotiations.

Vinay’s background is unique in that he is also a seasoned trial lawyer.  He is able to combine his regulatory expertise with a trial lawyer skillset for jury trials, bench trials, and arbitrations arising in the healthcare arena—he represents hospital systems, physician practices, providers of post-acute care services, as well as healthcare technology and revenue cycle management companies. He defends health care fraud and abuse litigation, prosecutes managed care disputes against large national payors, and handles government investigations.  And clients frequently call upon Vinay to serve as lead trial counsel in commercial litigation disputes that span the gamut from breach of contract and trade secret misappropriation to unfair business practices and breach of fiduciary claims.

Vinay received his B.B.A., magna cum laude, M.A., and J.D. from the University of Texas at Austin in 2005, 2006, and 2009 respectively.

Prior to joining Proskauer, Vinay was a partner in the Healthcare group at King & Spalding.

Photo of Matthew J. Westbrook Matthew J. Westbrook

Matt Westbrook is an associate in the Corporate Department and a member of the Health Care Group. His practice focuses on providing regulatory compliance advice for the Firm’s health care clients, including service providers, health plans, operators, investors, and lenders, among others. Matt…

Matt Westbrook is an associate in the Corporate Department and a member of the Health Care Group. His practice focuses on providing regulatory compliance advice for the Firm’s health care clients, including service providers, health plans, operators, investors, and lenders, among others. Matt specifically provides advice on fraud and abuse matters arising under the Federal False Claims Act (FCA), Civil Monetary Penalties Law, Federal Anti-Kickback Statute (AKS), and Physician Self-Referral Law (Stark Law), as well as on the regulations promulgated by the Drug Enforcement Administration (DEA) and the Department of Health and Human Services, including the Office of Inspector General (OIG), Centers for Medicare & Medicaid Services (CMS), and Food and Drug Administration (FDA).

Before joining the Firm, Matt served as senior counsel in OIG’s Administrative and Civil Remedies Branch. At OIG, Matt was responsible for determining whether to impose administrative sanctions, including civil money penalties and Federal health care program exclusions, against health care providers and suppliers, and whether to impose civil money penalties on hospitals and physicians in connection with matters referred to CMS under the Emergency Medical Treatment and Labor Act (EMTALA). During his tenure, Matt also litigated exclusion appeals before administrative law judges and appellate panels of the Departmental Appeals Board; advised United States Attorney’s Offices on exclusions appealed to Federal district courts; resolved voluntary self-disclosures submitted by providers and grant and contract recipients; and participated in the negotiations and settlements of FCA matters by the Department of Justice involving the AKS, Stark Law, CMS reimbursement issues, and DEA and FDA compliance issues. In connection with certain FCA resolutions, Matt also negotiated and monitored corporate integrity agreements.

On the Florida junior circuit and in college, Matt was a competitive tennis player. Matt played on the varsity team and was captain his senior year at Rhodes College, earning ITA Division III and SCAC All-Academic Honor Roll awards his sophomore, junior, and senior years. Matt is an active member of the American Health Law Association (AHLA) and currently serves as a Vice Chair of AHLA’s Fraud and Abuse Practice Group.

Photo of D. Austin Rettew D. Austin Rettew

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on…

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on managed care and commercial payer disputes, offering comprehensive regulatory, compliance, and reimbursement guidance to a diverse client base, including hospital systems, dialysis providers, anesthesia associations, physician practices, post-acute care service providers, and healthcare technology and revenue cycle management companies.

Austin is experienced in regulatory litigation and routinely advises clients operating within the complex landscape of the heavily regulated health care industry.  His work in this area addresses compliance issues related to ERISA, the Affordable Care Act, the Medicare Secondary Payer Act, the Medicare Advantage program, the federal No Surprises Act, state surprise billing laws, state insurance laws, and the Mental Health Parity and Addiction Equity Act.  He has represented providers, pharmaceutical manufacturers, and other health care companies in government investigations involving the Anti-Kickback Statute, the False Claims Act, and qui tam “whistleblower” lawsuits, working closely with company executives and consultants to develop effective compliance regimes while minimizing business disruption.

Austin also advises investors, owners, operators, and developers of long-term care and senior housing communities on health care transactions, regulatory compliance, corporate due diligence, and change of ownership procedures for state licensure, certificate of need, and Medicare and Medicaid certifications.  He also drafts industry-specific comment letters for proposed regulations, ensuring that client perspectives and concerns are clearly communicated to regulatory bodies.

While in law school, Austin was an articles editor of the George Washington University Law School’s Public Contract Law Journal.  Austin also served as a judicial intern for Judge Elizabeth S. Stong of the U.S. Bankruptcy Court for the Eastern District of New York and Magistrate Judge Lois Bloom of the U.S. District Court for the Eastern District of New York.

Prior to joining Proskauer, Austin was an associate in the Complex Litigation group at ArentFox Schiff.